An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome

ABSTRACT: The purpose of this study was to determine whether monthly deep subcutaneous (s.c.) injections of lanreotide Autogel (Somatuline Depot) were effective and safe in controlling diarrhoea and flushing by reducing the usage of s.c. short-acting octreotide as a rescue medication to control symptoms in subjects with carcinoid syndrome.

DISEASE(S): Malignant Carcinoid Syndrome,Flushing,Carcinoid Tumor,Diarrhoea,Carcinoid Syndrome,Serotonin Syndrome

PROVIDER: 2062737 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR